Reporter July 11 2014

July 10, 2014

Steaban, Edgeworth take on new adult enterprise roles

Robin Steaban, MSN, R.N., VUMC associate chief nursing officer and chief administrative officer at the Vanderbilt Heart and Vascular Institute, has been promoted to the newly created position of Chief Nursing Officer for Vanderbilt University Hospital and Clinics. In addition, Mitchell Edgeworth, MBA, chief operating officer for Vanderbilt University Hospital, has been promoted to the newly created position of Chief Operating Officer for Vanderbilt University Hospital and Clinics.

By John Howser
July 10, 2014

Molecular ‘chat’ holds kidney fibrosis clues

A novel molecular “conversation” regulates kidney fibrosis – the final result of end-stage chronic kidney disease – suggesting new treatment options for this currently irreversible process.

By Leigh MacMillan
July 10, 2014

Mathis named VUMC Chief Compliance Officer

James Mathis, J.D., Chief Clinical Enterprise Compliance Officer and assistant vice chancellor for Health Affairs, has been promoted to Chief Compliance Officer for Vanderbilt University Medical Center. In this new role he assumes broader oversight for the Medical Center’s compliance efforts.

By John Howser
July 10, 2014

Meranze, Penn named to new Faculty Affairs roles

Two veteran faculty members are assuming new roles as associate deans within Vanderbilt University School of Medicine’s Office of Faculty Affairs.

By Nancy Humphrey
July 10, 2014

Pietenpol named to IOM Cancer Policy Forum

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies.

By VUMC News and Communications
July 10, 2014

Photo: Residents ready

New members of Vanderbilt University Medical Center’s house staff hit the ground running last week.

By VUMC News and Communications
July 10, 2014

VU, Celgene announce research partnership

Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market.
By Bill Snyder
July 10, 2014

AHA grant creates coalition to prevent heart disease, stroke

Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world.
By Kathy Whitney
July 10, 2014

Happy anniversary

Current and former LifeFlight employees gathered recently at the Vanderbilt Recreation and Wellness Center to commemorate 30 years of service to the community.
By VUMC News and Communications
July 9, 2014

Study finds ‘hot’ frogs fight off fungal pathogen

Simple heat treatments may give the frog immune system a boost and help it fight off a deadly fungal pathogen, according to a new study published July 10 in the journal Nature.
By Leigh MacMillan
July 1, 2014

Vanderbilt selected to participate in Undiagnosed Diseases Network

Armed with a $7.2 million grant from the National Institutes of Health (NIH) Vanderbilt University Medical Center is one of six medical centers around the country selected to participate in a network to develop effective approaches for diagnosing hard-to-solve medical cases (undiagnosed diseases).
By Nancy Humphrey
June 27, 2014

VU introduces improved paper recycling through Cintas partnership

Vanderbilt recently renegotiated its contract with Cintas, Inc., resulting in lower costs and improved paper recycling options across the entire campus.
By VUMC News and Communications